ID   AMOC-2 Subclone #6
AC   CVCL_AT97
DR   Wikidata; Q54749822
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 25.40 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
RX   PubMed=9433040; DOI=10.1111/j.1447-0756.1997.tb00878.x;
RA   Yabushita, Hiromitsu
RA   Noguchi, Masayoshi
RA   Nakanishi, Masami
RT   "Emergence of an irreversible differentiated subclone from the poorly
RT   differentiated ovarian adenocarcinoma cell line AMOC-2 treated with
RT   sodium butyrate.";
RL   J. Obstet. Gynaecol. Res. 23:493-502(1997).
//